Drug Type Recombinant vector vaccine, Shared antigen vaccine |
Synonyms Marabex, AD MAGEA3, AD-MAGEA3 + [5] |
Target |
Mechanism MAGEA3 inhibitors(Melanoma-associated antigen 3 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
metastatic non-small cell lung cancer | Phase 2 | CA | 08 Mar 2017 | |
Non-Small Cell Lung Cancer | Phase 2 | CA | 08 Mar 2017 | |
Solid tumor | Phase 2 | CA | - | 22 Oct 2014 |
Cutaneous Squamous Cell Carcinoma | Phase 1 | - | 15 Feb 2020 | |
Melanoma | Phase 1 | - | 15 Feb 2020 | |
Metastatic melanoma | Phase 1 | - | 15 Feb 2020 | |
Squamous Cell Carcinoma | Phase 1 | - | 15 Feb 2020 |